欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/4455/001
药品名称Strefen Direct 8.75mg Spray
活性成分
    • flurbiprofen 1.62 % (W/V)
剂型Oromucosal spray
上市许可持有人RECKITT BENCKISER HEALTHCARE (UK) LIMITED 103-105 BATH ROAD SLOUGH BERKSHIRE SL1 3UH UNITED KINGDOM
参考成员国 - 产品名称Netherlands (NL)
Strepfen 8,75 mg keelspray
互认成员国 - 产品名称
    • Germany (DE)
      Dobendan Direkt Flurbiprofen 8,75 mg Spray
    • Belgium (BE)
      Strepfen Spray 8,75 mg/dose spray voor oromucosaal gebruik, oplossing
    • Luxembourg (LU)
    • Ireland (IE)
    • Austria (AT)
      Strepsils 8,75 mg/Dosis Spray zur Anwendung in der Mundhöhle, Lösung
    • Spain (ES)
    • Italy (IT)
    • Poland (PL)
      Strepsils Intensive Direct
    • Hungary (HU)
      STREPFEN DIREKT 16,2 mg/ml szájnyálkahártyán alkalmazott oldatos spray
    • Bulgaria (BG)
      Strepsils Intensive Spray
    • Czechia (CZ)
      Strepfen Direct 8,75 mg Spray
    • Romania (RO)
      STREPSILS INTENSIV 8,75 mg/doză spray bucofaringian, soluţie
    • Slovakia (SK)
      Strepfen Sprej 8,75 mg orálna roztoková aerodisperzia
    • Denmark (DK)
    • Iceland (IS)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Latvia (LV)
    • Lithuania (LT)
      Strefen 16,2 mg/ml burnos gleivinės purškalas (tirpalas)
    • Estonia (EE)
    • Cyprus (CY)
      STREPFEN SPRAY 8.75 MG
    • Slovenia (SI)
    • Croatia (HR)
    • Portugal (PT)
许可日期2014/09/25
最近更新日期2024/04/26
药物ATC编码
    • R02AX01 flurbiprofen
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase